Skip to main content
Clinical Trials/NCT04867473
NCT04867473CompletedNot Applicable

Teleyoga for Lyme Disease

Stanford University2 sites in 1 country15 target enrollmentStarted: October 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
15
Locations
2
Primary Endpoint
Change of Pain Score From Baseline

Study Overview

Brief Summary

Primary Aims: Modify an existing teleyoga intervention to use with Lyme disease (LD) patients and address the technical challenges of at-home teleyoga

Detailed Description

Participants with symptoms of Lyme disease (n=15) will participate individually in a weekly tele-yoga class using an iPad loaned by the study. Participants will choose where to attend these remote treatment sessions. Yoga treatment will last 12 weeks. Participants' subjective pain will be rated at baseline and end-of-treatment using a standard pain scale. Also assessed will be participant adherence to study protocol by tracking treatment attendance

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of probable Lyme disease
  • Has not begun new pain medications or other treatments in the last month
  • English literacy
  • Wireless internet connection at home

Exclusion Criteria

  • Participation in another concurrent clinical trial
  • Back surgery within the last 12 months
  • Unstable, coexisting mental illness or psychiatric condition
  • Active, current suicidal intent or plan
  • Attended or practiced yoga ≥ 1 x in the past 12 months

Outcomes

Primary Outcomes

Change of Pain Score From Baseline

Time Frame: Measured at baseline and again at the end of 12 weeks of treatment

Scores on the Pain, Enjoyment, General Activity (PEG) Scale; with values from 0 to 10 and higher scores indicating worse outcomes

Secondary Outcomes

  • Adherence to the Treatment Protocol(at study completion, an average of 7 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Peter Bayley

Investigator

Stanford University

Study Sites (2)

Loading locations...

Similar Trials